7733 — Olympus Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Olympus, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	755,231	730,544	750,123	881,923	936,210
Cost of Revenue
Gross Profit	482,775	459,530	506,700	596,849	625,123
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	663,031	648,559	603,935	695,314	892,612
Operating Profit	92,200	81,985	146,188	186,609	43,598
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	86,617	76,810	141,701	182,294	35,854
Provision for Income Taxes
Net Income After Taxes	60,582	65,670	110,627	137,990	26,973
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	51,670	12,918	115,742	143,432	242,566
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	51,670	12,918	115,742	143,432	242,566
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	49.1	63.6	89.9	100	86.4
Dividends per Share